Big boost to India’s fight against Covid-19, says Health Min on India’s first nasal vaccine

Delhi, Sept 7th,2022: India’s first nasal Covid vaccine by Bharat Biotech received DCGI approval on Tuesday for primary immunization against the infection for people above the age of 18. Lauding the achievement, Health Minister Dr. Mansukh Mandaviya said, it is a ‘Big Boost to India’s Fight Against COVID-19′.

“India has harnessed its science, research and development, and human resources… under PM Narendra Modi’s leadership,” the minister said.

He further tweeted that the nasal vaccine has been approved for restricted use in emergency situations for people above the age of 18.

Bharat Biotech said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose, for subjects who have been double vaccinated with the two commonly administered Covid vaccines in India.

“It has proven to be safe, well-tolerated, and immunogenic in subjects in controlled trials” BBIL said in a statement.

As for the pandemic status today, India saw a single-day rise of 4,417 coronavirus infections, which is the lowest in three months, as per government data updated on Tuesday morning.